Monthly Archives: April 2017

Alzheimers Association upset with CMS draft decision on brain amyloid imaging Alzheimer&39.

. Individuals meeting testing for possible Alzheimer's, but who all are unusual within their clinical presentation. Individuals with progressive dementia and atypically early age of onset . As the biggest scientifically-based patient advocacy group in neuro-scientific Alzheimer's and dementia, the Alzheimer's Association strongly helps early and accurate analysis of Alzheimer's disease. We encourage CMS to have an open dialogue with… (more…)

PRESS RELEASE WOONSOCKET.

One year back, we stopped offering tobacco products because it conflicted with our purpose of helping people on their path to better health, stated Troyen A. Brennan, M.D., M.P.H., Chief Medical Officer, CVS Health. Today, we are excited to release fresh data demonstrating the positive impact our decision has already established on public health overall as shown by a measurable… (more…)

Progress towards this goal has been too slow to date.

This will demand linking genetic information from patients’ tissue samples to top quality data on whether they take advantage of the treatment, and for how long that benefit lasts. The specialised tools and expertise necessary to uncover a tumour’s genetic fingerprint imply that trials will be expensive to run. But scientists believe the outcome could be hugely improved efficiency in… (more…)